.jpg)
Japan's Marubeni takes on Sumitomo's Asia pharma business to make new company in deal worth up to $480M
Japanese conglomerate Marubeni is getting a 60% stake in the new company for 45 billion yen ($300 million), but can get the remaining 40% for 45 billion yen ($300 million) after 2029.
Japanese conglomerate Marubeni is getting a 60% stake in the new company for 45 billion yen ($300 million), but can get the remaining 40% for 45 billion yen ($300 million) after 2029.
